ipriflavone has been researched along with Chronic Kidney Failure in 2 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ipriflavone is a recently introduced anti-osteoporotic agent extensively metabolized to four major metabolites (M1, M2, M3, M5)." | 1.28 | Steady-state pharmacokinetics of ipriflavone and its metabolites in patients with renal failure. ( Acerbi, D; Rondelli, I; Ventura, P, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugimura, T | 1 |
| Rondelli, I | 1 |
| Acerbi, D | 1 |
| Ventura, P | 1 |
2 other studies available for ipriflavone and Chronic Kidney Failure
| Article | Year |
|---|---|
[Research on the treatment of secondary hyperparathyroidism as a complication of chronic renal failure].
Topics: Acid Phosphatase; Alkaline Phosphatase; Aluminum; Bone Density; Calcitonin; Calcitriol; Drug Adminis | 1991 |
Steady-state pharmacokinetics of ipriflavone and its metabolites in patients with renal failure.
Topics: Adult; Aged; Female; Humans; Isoflavones; Kidney Failure, Chronic; Male; Middle Aged; Osteoporosis | 1991 |